(Press-News.org) Brains of older adults with super healthy cognition grow more new neurons than those of their peers, according to a study from UIC, Northwestern University and the University of Washington. Researchers found that the brains of superagers — octogenarians with uncommonly nimble minds — were the most neuronally fertile, while those with Alzheimer’s disease had negligible new growth.
“This is a big step forward in understanding how the human brain processes cognition, forms memories and ages. Determining why some brains age more healthily than others can help researchers make therapeutics for healthy aging, cognitive resilience and the prevention of Alzheimer’s disease and related dementia,” said Orly Lazarov, a professor in UIC’s College of Medicine and director of the Alzheimer’s Disease and Related Dementia Training Program.
Neurons, or brain cells, support almost every human function. When you wiggle a toe or snap a finger, a neuron zaps a signal from your brain to your nervous system. In the latter half of the 20th century, researchers determined that new neurons could spawn throughout the lifespan in the brain’s hippocampus, or memory center — a phenomenon called adult neurogenesis.
At first, scientists observed neurogenesis in rodents and were skeptical about whether it would appear in other mammals. Then, studies in primates linked neurogenesis to healthier aging brains, particularly stronger memory formation and processing.
This recent study, published in Nature, affirms that neurogenesis occurs in adult humans as well.
The researchers looked at donated brain samples from five groups: healthy young adults; healthy older adults; older adults with exceptional memory, or superagers; individuals with mild or early dementia; and those diagnosed with Alzheimer’s disease.
The superager brains in the samples came from donors aged 80 years or older with exceptional memory skills. Brain samples from superagers were obtained from Northwestern University. The University of Washington supplied all other samples.
The researchers searched for three stages of developing neurons in the brains’ hippocampi: stem cells, which could potentially evolve into neurons; neuroblasts, adolescent stem cells on their way to neuronhood; and immature neurons, which are just shy of becoming functional.
“Think of the stages of adult neurogenesis like a baby, a toddler and a teenager,” Lazarov said. “All are signs that these hippocampi are growing new neurons.”
Results indicated that hippocampal neurogenesis, or the formation of new neurons in the hippocampus, does indeed occur in healthy human adults. Further, superagers actively produced more new neurons than their counterparts — their distinct “resilience signature.”
“Superagers had twice the neurogenesis of the other healthy older adults,” Lazarov said. “Something in their brains enables them to maintain a superior memory. I believe hippocampal neurogenesis is the secret ingredient, and the data support that.”
Brain samples from individuals with preclinical cognitive decline — the earliest stage of cognitive decline, before symptoms start to appear — displayed minimal neurogenesis. Those diagnosed with Alzheimer’s disease generated almost no new neurons.
Further, the researchers observed that the new neurons had different epigenetic signatures — or blueprints for responding to environmental change — depending on the brains’ cognitive health.
“Modern medicine has revolutionized health care such that life expectancy is greater now than ever before,” said co-lead author Dr. Jalees Rehman, the Benjamin J. Goldberg Professor and head of the department of biochemistry and molecular genetics at UIC. “We need to ensure that this overall increased life expectancy goes along with a high quality of life, including cognitive health.”
Rehman said that understanding the full molecular picture of neurogenesis and its epigenetic signature can inform targeted therapeutics to preserve memory and cognitive function in aging adults. Next, this team will examine environmental and lifestyle factors — like diet, exercise and inflammation — that may work alongside neurogenesis to impact aging.
“What’s exciting for the public is that this study shows the aging brain is not fixed or doomed to decline,” said Ahmed Disouky, the first author of the study. “Understanding how some people naturally maintain neurogenesis opens the door to strategies that could help more adults preserve memory and cognitive health as they age.”
Additional UIC coauthors include Mark Sanborn, K. R. Sabitha, Mark Maienschein-Cline and Mostafa Mostafa from the College of Medicine.
Brain and tissue samples were obtained from the University of Washington Alzheimer’s Disease Research Center, the Adult Changes in Thought study, the Pacific Northwest Brain Donor Network, the Allen Institute for Brain Science, the Northwestern University Alzheimer’s Disease Research Center, the SuperAging Research Initiative, the Karen Toffler Charitable Trust and the Gefen-Querrey Brain Health Fund. The study was supported by the National Institute on Aging awards AG033570, AG033570-S2, AG076940, AGO79002, AG060238, AG061628 and AG091545.
END
Superagers’ brains have a ‘resilience signature,’ and it’s all about neuron growth
2026-02-25
ELSE PRESS RELEASES FROM THIS DATE:
New research sheds light on why eczema so often begins in childhood
2026-02-25
[New York, NY [February 25, 2026]—A team of researchers at the Icahn School of Medicine at Mount Sinai, Weill Cornell Medicine, and other institutions have uncovered a key biological explanation for why eczema so often starts in childhood. The study, in young mice, found that some types of immune cells in early-life skin are more reactive than those in adults, a difference that may help explain why children are more vulnerable to inflammation and allergic skin disease.
The findings suggest that early childhood represents a critical window for immune-driven ...
Small models, big insights into vision
2026-02-25
Small models, big insights into vision
Understanding how the brain processes what we see is one of the central questions in neuroscience. Our visual system is incredibly powerful, able to recognize faces, objects, and scenes with ease, yet the details of how individual neurons respond to images remain complex and difficult to study. A new study published in Nature shows that it is possible to capture these responses using models that are both highly accurate and far simpler than previous approaches.
The team began with a large computer model designed to predict how neurons in the visual cortex ...
Finding new ways to kill bacteria
2026-02-25
The scientists report their findings in the February 26 issue of the journal Nature. The lead author of the paper is Yancheng Evelyn Li, a graduate student in the lab of Bil Clemons, the Arthur and Marian Hanisch Memorial Professor of Biochemistry at Caltech, who is the corresponding author.
"Evolution is powerful, and in bacteria, resistance to antibiotics develops quickly. This means that we now deal with bacteria that are resistant to all the medicines that we have," Clemons says. "In the USA alone, tens of thousands of people die every year from antibiotic-resistant bacterial infections, ...
An endangered natural pharmacy hidden in coral reefs
2026-02-25
Coral reefs are teeming with life: they are home to over a third of all marine animal and plant species on Earth, despite covering less than one percent of the ocean floor. However, this immense diversity is under threat from rising ocean temperatures. Since the 1950s, half of the world’s coral population has already disappeared.
Beyond the reef’s visible inhabitants, countless microorganisms are also under threat. These often live in symbiosis with corals, sponges and other reef dwellers, which benefits them ...
The Frontiers of Knowledge Award goes to Charles Manski for incorporating uncertainty into economic research and its application to public policy analysis
2026-02-25
The BBVA Foundation Frontiers of Knowledge Awards in Economics, Finance and Management has gone in this eighteenth edition to Charles F. Manski for his pioneering contributions to the measurement of uncertainty in economic research and its application to public policy analysis. The professor at Northwestern University (Chicago, United States) is described by the committee as a “foundational figure” in the development of modern methods that have transformed how economists infer conclusions from data, report degrees of uncertainty in their models, ...
Walter Koroshetz joins Dana Foundation as senior advisor
2026-02-25
NEW YORK, February 24, 2026 – The Dana Foundation today announced Walter Koroshetz, M.D., FAAN, will join the organization as a senior advisor, effective March 1, in support of its mission to advance neuroscience that benefits society and reflects the aspirations of all people. Koroshetz, who oversaw the federal government’s largest neuroscience research portfolio as director of the National Institute of Neurological Disorders and Stroke (NINDS), will work with the Foundation’s leadership to guide science funding collaborations and support for early-career scholars and ...
Next-generation CAR-T designs that could transform cancer treatment
2026-02-25
“CAR T-cell therapy has emerged as a particularly promising cancer-specific treatment strategy.”
BUFFALO, NY – February 25, 2026 – A new editorial perspective was published in Volume 17 of Oncotarget on February 20, 2026, titled “CAR-T therapy: Trailblazing CAR(ing) in cancer treatment.”
Led by Uzma Saqib — with corresponding author Krishnan Hajela from the School of Life Sciences, Devi Ahilya Vishwavidyalaya — the perspective reviews recent clinical and translational advances in chimeric antigen receptor T-cell (CAR-T) therapy and highlights both its promise ...
As health care goes digital, patients are being left behind
2026-02-25
Patients are now expected to navigate much of their care online — from seeing their doctor on a screen to booking appointments, refilling prescriptions, and checking test results through health care portals.
Yet, according to a new study by UC San Francisco, most health systems are skipping a crucial step: asking whether their patients have the access and skills to use these digital tools.
The researchers surveyed nearly 150 clinicians and informatics leaders from health care systems across the country during the first half of 2024. Just 44% said they asked their patients if they could use digital devices. Among the ...
A clinicopathologic analysis of 740 endometrial polyps: risk of premalignant changes and malignancy
2026-02-25
Background and objectives
Endometrial polyp (EMP) is one of the most common diagnoses in the evaluation of women with abnormal uterine bleeding. Understanding the malignancy risk associated with EMPs and related risk factors is essential for guiding both pathology practice and clinical management. This study aimed to explore risk factors for malignancy in EMPs.
Methods
The pathology database was searched for women diagnosed with EMP between 2021 and 2022. Patient age, polyp size, background endometrium, recurrence, and (if applicable) cancer types were recorded. Immunohistochemistry (IHC) for p53 and p16 was performed on selected cases. Risk factors for malignancy were analyzed using Chi-square ...
Gibson Oncology, NIH to begin Phase 2 trials of LMP744 for treatment of first-time recurrent glioblastoma
2026-02-25
WEST LAFAYETTE, Ind. and MIAMI — Gibson Oncology, a clinical-stage private pharmaceutical company headquartered in Miami, announced it has entered Phase 2 clinical trials with LMP744 for the treatment of first-time recurrent glioblastoma patients.
The company is focused on advancing its novel small molecules with dual-action inhibition of topoisomerase 1 and reduction of overexpression of the cMYC oncogene.
“The primary endpoint of the study is to evaluate tumor regression in patients with recurrent glioblastoma. Secondary endpoints will evaluate parameters such as progression-free survival, biological changes in glioblastoma tissues obtained pre- and post-treatment, ...